Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a Con-call has been arranged by PhillipCapital (India) with A. Velumani, Chairman, Managing Director and CEO of the company, to discuss on Covid-19 and its impact on Indian Healthcare, at 02.30 PM today, Wednesday, March 18, 2020. The con-call arranged through Prabhudas Lilladher on the same topic has been deferred. This is subject to any last minute changes.
The above information is a part of company's filings submitted to BSE.
